DEA schedule
Is Focalin a controlled substance?
Focalin contains dexmethylphenidate. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Focalin (dexmethylphenidate) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Focalin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 19 prescription listings from 2 labelers, all Schedule II |
| DEA controlled substances list | Methylphenidate: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Methylphenidate | 1724 | II | No | Concerta; Ritalin; Methylin | Isomer or salt of the listed substance (21 CFR 1308) |
Focalin NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0431 | Focalin XR | capsule, extended release | 10 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-236 | Focalin XR | capsule, extended release | 10 mg/1 | Sandoz Inc | CII |
| 0078-0493 | Focalin XR | capsule, extended release | 15 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-237 | Focalin XR | capsule, extended release | 15 mg/1 | Sandoz Inc | CII |
| 0078-0432 | Focalin XR | capsule, extended release | 20 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-238 | Focalin XR | capsule, extended release | 20 mg/1 | Sandoz Inc | CII |
| 0078-0608 | Focalin XR | capsule, extended release | 25 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-239 | Focalin XR | capsule, extended release | 25 mg/1 | Sandoz Inc | CII |
| 0078-0433 | Focalin XR | capsule, extended release | 30 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-240 | Focalin XR | capsule, extended release | 30 mg/1 | Sandoz Inc | CII |
| 0078-0609 | Focalin XR | capsule, extended release | 35 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-241 | Focalin XR | capsule, extended release | 35 mg/1 | Sandoz Inc | CII |
| 0078-0434 | Focalin XR | capsule, extended release | 40 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-242 | Focalin XR | capsule, extended release | 40 mg/1 | Sandoz Inc | CII |
| 0078-0430 | Focalin XR | capsule, extended release | 5 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-235 | Focalin XR | capsule, extended release | 5 mg/1 | Sandoz Inc | CII |
| 66758-252 | Focalin | tablet | 10 mg/1 | Sandoz Inc | CII |
| 66758-250 | Focalin | tablet | 2.5 mg/1 | Sandoz Inc | CII |
| 66758-251 | Focalin | tablet | 5 mg/1 | Sandoz Inc | CII |
Questions
Is Focalin a controlled substance?
Yes. Focalin (dexmethylphenidate) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Is Focalin a narcotic?
No. The DEA list does not mark dexmethylphenidate as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is Focalin?
Focalin is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Focalin
- What is Focalin used for?FDA label uses
- Generic for FocalinFDA Orange Book
- What is Dexmethylphenidate used for?FDA label uses
- Is Dexmethylphenidate a controlled substance?Schedule II
- Generic for Focalin XRFDA Orange Book
- Central Nervous System Stimulants listFDA drug class
- NDC 0078-0430Focalin NDC record
- NDC 0078-0431Focalin NDC record
- NDC 0078-0432Focalin NDC record
- Schedule II drugs listDEA schedule